China Pharma Holdings (CPHI) Cash from Operations (QoQ) (2010 - 2026)
China Pharma Holdings (CPHI) Cash from Operations (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | China Pharma Holdings | 41.38 Mn | 41.08 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -136.38% |
| Dec 31, 2025 | 164.13% |
| Sep 30, 2025 | -177.21% |
| Jun 30, 2025 | 516.60% |
| Mar 31, 2025 | -124.66% |
| Dec 31, 2024 | 736.34% |
| Sep 30, 2024 | 35.44% |
| Jun 30, 2024 | 87.57% |
| Mar 31, 2024 | -2,521.32% |
| Dec 31, 2023 | -102.22% |
| Sep 30, 2023 | 565.40% |
| Jun 30, 2023 | 85.26% |
| Mar 31, 2023 | -351.15% |
| Dec 31, 2022 | 166.79% |
| Sep 30, 2022 | 165.64% |
| Jun 30, 2022 | 62.04% |
| Mar 31, 2022 | -343.91% |
| Dec 31, 2021 | 56.06% |
| Sep 30, 2021 | -166.69% |
| Jun 30, 2021 | 344.13% |